NLRP3 and metabolic dysfunction-associated steatotic liver disease: Given the important role of the NLRP3 inflammasome in inflammatory responses, we also have reason to infer the therapeutic prospects of IAld for other NLRP3-related inflammatory diseases such as Alzheimer’s disease (AD), nonalcoholic fatty liver disease (NAFLD), and multiple sclerosis (MS).